To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma

NCT02260804 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
258
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celltrion